Nuvectis Pharma Inc (NASDAQ:NVCT)’s traded shares stood at 0.34 million during the last session, with the company’s beta value hitting -0.04. At the close of trading, the stock’s price was $10.20, to imply an increase of 9.09% or $0.85 in intraday trading. The NVCT share’s 52-week high remains $11.80, putting it -15.69% down since that peak but still an impressive 56.47% since price per share fell to its 52-week low of $4.44. The company has a valuation of $238.59M, with an average of 0.15 million shares in intraday trading volume over the past 10 days and average of 111.79K shares over the past 3 months.
Nuvectis Pharma Inc (NASDAQ:NVCT) trade information
After registering a 9.09% upside in the last session, Nuvectis Pharma Inc (NVCT) has traded red over the past five days. The 5-day price performance for the stock is 15.25%, and 35.64% over 30 days. With these gigs, the year-to-date price performance is 88.54%. Short interest in Nuvectis Pharma Inc (NASDAQ:NVCT) saw shorts transact 1.34 million shares and set a 11.14 days time to cover.
An assessment of the company’s 5-year growth patterns shows that annual earnings shrunk an estimated -510.36% for the past 5-year period. While 2025 is set for a 7.88% return in earnings, projections for the next 5 years are at 18.43% annually.
NVCT Dividends
Nuvectis Pharma Inc has its next earnings report out on 2025-Feb-24. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Nuvectis Pharma Inc (NASDAQ:NVCT)’s Major holders
Nuvectis Pharma Inc insiders hold 45.35% of total outstanding shares, with institutional holders owning 6.92% of the shares at 12.67% float percentage. In total, 6.92% institutions holds shares in the company, led by VANGUARD GROUP INC. As of 2024-06-30, the company held over 0.25 million shares (or 1.5166% of shares), all amounting to roughly $1.59 million.
The next major institution holding the largest number of shares is BALDWIN BROTHERS LLC/MA with 0.17 million shares, or about 0.9978% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $1.07 million.
We also have Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the Nuvectis Pharma Inc (NVCT) shares. Going by data provided on Dec 31, 2024 , Vanguard Total Stock Market Index Fund holds roughly 231.04 shares. This is just over 0.99% of the total shares, with a market valuation of $2.36 million. Data from the same date shows that the other fund manager holds a little less at 81.75, or 0.35% of the shares, all valued at about 0.83 million.
